Summary: Although the gold standard for medical abortion care worldwide has been the use of mifepristone, a drug that terminates pregnancy, the medication was only recently approved in Canada in July 2015. The introduction of mifepristone presents an exceptional opportunity to better understand the effectiveness of health care provider training on adoption of medical abortion into practice and the impact on access to abortion, particularly for women in rural and remote areas.
We are currently raising awareness about the safety and access implications of Health Canada’s request for dispensary by physicians only. Read more here
